Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Predictive Oncology Inc (POAI)

Predictive Oncology Inc (POAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,974
  • Shares Outstanding, K 6,667
  • Annual Sales, $ 1,780 K
  • Annual Income, $ -13,980 K
  • EBIT $ -13 M
  • EBITDA $ -13 M
  • 60-Month Beta 1.19
  • Price/Sales 2.57
  • Price/Cash Flow N/A
  • Price/Book 2.33
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.93
  • Most Recent Earnings $-0.36 on 11/12/24
  • Next Earnings Date 11/11/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.25
  • Number of Estimates 1
  • High Estimate -0.25
  • Low Estimate -0.25
  • Prior Year -0.85
  • Growth Rate Est. (year over year) +70.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6600 +13.03%
on 12/23/24
0.8800 -15.23%
on 12/10/24
+0.0260 (+3.61%)
since 11/22/24
3-Month
0.5500 +35.64%
on 10/15/24
0.9400 -20.64%
on 10/28/24
-0.0498 (-6.26%)
since 09/24/24
52-Week
0.5500 +35.64%
on 10/15/24
3.7600 -80.16%
on 02/22/24
-2.4140 (-76.39%)
since 12/22/23

Most Recent Stories

More News
Predictive Oncology Inc. Advances Strategic Alternatives Evaluation to Maximize Shareholder Value

Predictive Oncology Inc. evaluates strategic alternatives, including potential sales and partnerships, to enhance shareholder value.Quiver AI SummaryPredictive Oncology Inc. has announced advancements...

POAI : 0.7460 (+8.75%)
Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives

POAI : 0.7460 (+8.75%)
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update

POAI : 0.7460 (+8.75%)
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:POAI),(NASDAQ:AGLE),(NASDAQ:TALS),(NASDAQ:MRTX) EQNX::TICKER_END

ONCY : 0.9700 (+7.09%)
ONC.TO : 1.41 (+9.30%)
AGLE : 12.01 (+8.79%)
TALS : 27.20 (-0.73%)
POAI : 0.7460 (+8.75%)
MRTX : 58.70 (-0.17%)
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs

/PRNewswire/ -- Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other...

ONC.TO : 1.41 (+9.30%)
ONCY : 0.9700 (+7.09%)
AGLE : 12.01 (+8.79%)
TALS : 27.20 (-0.73%)
POAI : 0.7460 (+8.75%)
MRTX : 58.70 (-0.17%)
Predictive Oncology Strengthens Business with Appointment of a Chief Scientific Officer and Consolidation and Expansion of its Research and Development Arm

EAGAN, Minn., July 26, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced a strategic move to further strengthen its business...

POAI : 0.7460 (+8.75%)
Predictive Oncology Announces Closing of $7.2 Million Registered Direct Offerings

EAGAN, Minn., May 18, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven...

POAI : 0.7460 (+8.75%)
Predictive Oncology Announces $7.2 Million Registered Direct Offerings

EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven...

POAI : 0.7460 (+8.75%)
Predictive Oncology Reports First Quarter Financial Results

EAGAN, Minn., May 12, 2022 (GLOBE NEWSWIRE) -- The financial results from the first quarter we believe depicts a solid potential for growth in the...

POAI : 0.7460 (+8.75%)
Marketer with over 20 years of experience selected to head up marketing at Predictive Oncology

EAGAN, Minn., April 26, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced that Theresa Ferguson has been named Senior Director...

POAI : 0.7460 (+8.75%)

Business Summary

Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.

See More

Key Turning Points

3rd Resistance Point 0.8207
2nd Resistance Point 0.7833
1st Resistance Point 0.7647
Last Price 0.7460
1st Support Level 0.7087
2nd Support Level 0.6713
3rd Support Level 0.6527

See More

52-Week High 3.7600
Fibonacci 61.8% 2.5338
Fibonacci 50% 2.1550
Fibonacci 38.2% 1.7762
Last Price 0.7460
52-Week Low 0.5500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar